Cathy Clarke, PhD, is currently the Global Health Economics and Payer Evidence Lead at AstraZeneca, specializing in oncology with a strong background in medical affairs. Previously, they served as HEOR Manager at Novartis Oncology and gained extensive experience in various roles within GSK. Cathy completed a postdoctoral fellowship at Memorial Sloan-Kettering Cancer Center, where they contributed to the development of targeted anti-cancer drugs. They hold a PhD in the role of radioiodide in breast cancer therapy from University College Dublin, along with a Master's in the evaluation of healthcare from City, University of London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices